Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.18%
#3 CoW Protocol CoW Protocol +44.40%
#4 Glidr Glidr +36.87%
#5 Humanity Humanity +26.78%
#6 Walrus Walrus +24.24%
#7 Codatta Codatta +19.91%
#8 Enso Enso +18.69%
#9 Collector Crypt Collector Crypt +14.14%
#10 The Black Bull The Black Bull +13.35%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Allegra Medical Technologies Limited Allegra Medical Technologies Limited

Allegra Medical Technologies Limited

AMT
Rank in Stocks #36664
Allegra Medical Technologies Limited, established in Lane Cove West, Australia,... Allegra Medical Technologies Limited, established in Lane Cove West, Australia, in 1994 (and known as Advanced Surgical Design & Manufacture Limited until its name change in November 2014), is a company focused on the design, sales, and distribution of medical devices throughout Australia and New Zealand. Its operations are segmented into an Orthopedics Division and an Innovation Division. The company offers a comprehensive range of orthopedic products, addressing various anatomical needs. For the upper body, this includes fixation systems for both adult and adolescent clavicles, as well as a selection of symmetrical and asymmetrical offsets for shoulder procedures. Solutions for the hand and wrist comprise advanced offerings like StripEase, distal radius systems, compression screws, hand fracture systems, ulna shortening plates, and modular ceramic or CoCr heads. In the realm of joint replacement and reconstruction, Allegra provides an array of hip-related products such as reconstruction prostheses, modular tumor and revision systems, partial pelvis replacements, various standard and revision stems (both cementless and cemented), and diverse acetabular cup systems, including ceramic and CoCrMo prosthesis heads. For the knee, their portfolio features the ActiveKnee total knee replacement prosthesis and its accompanying surgical instruments. Foot and ankle solutions encompass total ankle replacement systems, DF toe, A-curve handles, screws, activ fuse, and plating systems. Beyond these specialized implants, the company also supplies general surgical consumables like sawblades, kirschner wires, and pins. Additionally, Allegra offers innovative solutions such as NanoFx for microfracture procedures and a variety of instrument sets tailored for different surgical requirements, including post-surgery rehabilitation, shoulder surgery, direct anterior approach, PCL protection, and revision surgery.
Share Price
$0.02045326
Last synced: 2024-07-24
Market Cap
$2.45M
Change (1 day)
7.75%
Change (1 year)
0.00%
Country
AU
Trade Allegra Medical Technologies Limited (AMT)

Category

Healthcare
P/E ratio for Allegra Medical Technologies Limited (AMT)
P/E ratio as of 2026 TTM: 0
According to Allegra Medical Technologies Limited latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Allegra Medical Technologies Limited from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 35.77 -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 34.86 -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 20.90 -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 52.64 -
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.